1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Melatonin 1.2.3 Ramelteon 1.2.4 Others 1.3 Market by Application 1.3.1 Global Circadian Rhythm Sleep Disorders Drug Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Delayed Sleep Phase Syndrome (DSPS) 1.3.3 Advanced Sleep Phase Syndrome (ASPS) 1.3.4 Irregular Sleep-Wake Disorder (ISWD) 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Circadian Rhythm Sleep Disorders Drug Market Perspective (2018-2029) 2.2 Circadian Rhythm Sleep Disorders Drug Growth Trends by Region 2.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Circadian Rhythm Sleep Disorders Drug Historic Market Size by Region (2018-2023) 2.2.3 Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2024-2029) 2.3 Circadian Rhythm Sleep Disorders Drug Market Dynamics 2.3.1 Circadian Rhythm Sleep Disorders Drug Industry Trends 2.3.2 Circadian Rhythm Sleep Disorders Drug Market Drivers 2.3.3 Circadian Rhythm Sleep Disorders Drug Market Challenges 2.3.4 Circadian Rhythm Sleep Disorders Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue 3.1.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue (2018-2023) 3.1.2 Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Players (2018-2023) 3.2 Global Circadian Rhythm Sleep Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Circadian Rhythm Sleep Disorders Drug Revenue 3.4 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio 3.4.1 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Circadian Rhythm Sleep Disorders Drug Revenue in 2022 3.5 Circadian Rhythm Sleep Disorders Drug Key Players Head office and Area Served 3.6 Key Players Circadian Rhythm Sleep Disorders Drug Product Solution and Service 3.7 Date of Enter into Circadian Rhythm Sleep Disorders Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Type 4.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Type (2018-2023) 4.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2024-2029) 5 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Application 5.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Application (2018-2023) 5.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Circadian Rhythm Sleep Disorders Drug Market Size (2018-2029) 6.2 North America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) 6.4 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2018-2029) 7.2 Europe Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) 7.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size (2018-2029) 8.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2018-2023) 8.4 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size (2018-2029) 9.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) 9.4 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size (2018-2029) 10.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) 10.4 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Teva Pharmaceuticals 11.1.1 Teva Pharmaceuticals Company Detail 11.1.2 Teva Pharmaceuticals Business Overview 11.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Introduction 11.1.4 Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.1.5 Teva Pharmaceuticals Recent Development 11.2 Takeda Pharmaceutical 11.2.1 Takeda Pharmaceutical Company Detail 11.2.2 Takeda Pharmaceutical Business Overview 11.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Introduction 11.2.4 Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.2.5 Takeda Pharmaceutical Recent Development 11.3 NBTY 11.3.1 NBTY Company Detail 11.3.2 NBTY Business Overview 11.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Introduction 11.3.4 NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.3.5 NBTY Recent Development 11.4 Vicks (Procter & Gamble) 11.4.1 Vicks (Procter & Gamble) Company Detail 11.4.2 Vicks (Procter & Gamble) Business Overview 11.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Introduction 11.4.4 Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.4.5 Vicks (Procter & Gamble) Recent Development 11.5 Natrol 11.5.1 Natrol Company Detail 11.5.2 Natrol Business Overview 11.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Introduction 11.5.4 Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.5.5 Natrol Recent Development 11.6 Nature Made (Pharmavite) 11.6.1 Nature Made (Pharmavite) Company Detail 11.6.2 Nature Made (Pharmavite) Business Overview 11.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Introduction 11.6.4 Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.6.5 Nature Made (Pharmavite) Recent Development 11.7 Jameison 11.7.1 Jameison Company Detail 11.7.2 Jameison Business Overview 11.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Introduction 11.7.4 Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.7.5 Jameison Recent Development 11.8 GNC 11.8.1 GNC Company Detail 11.8.2 GNC Business Overview 11.8.3 GNC Circadian Rhythm Sleep Disorders Drug Introduction 11.8.4 GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.8.5 GNC Recent Development 11.9 By-Health 11.9.1 By-Health Company Detail 11.9.2 By-Health Business Overview 11.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Introduction 11.9.4 By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.9.5 By-Health Recent Development 11.10 Now Foods 11.10.1 Now Foods Company Detail 11.10.2 Now Foods Business Overview 11.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Introduction 11.10.4 Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.10.5 Now Foods Recent Development 11.11 Vitafusion (Church & Dwight) 11.11.1 Vitafusion (Church & Dwight) Company Detail 11.11.2 Vitafusion (Church & Dwight) Business Overview 11.11.3 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Introduction 11.11.4 Vitafusion (Church & Dwight) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.11.5 Vitafusion (Church & Dwight) Recent Development 11.12 OLLY (Unilever) 11.12.1 OLLY (Unilever) Company Detail 11.12.2 OLLY (Unilever) Business Overview 11.12.3 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Introduction 11.12.4 OLLY (Unilever) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.12.5 OLLY (Unilever) Recent Development 11.13 Doctor's Best (Kingdomway) 11.13.1 Doctor's Best (Kingdomway) Company Detail 11.13.2 Doctor's Best (Kingdomway) Business Overview 11.13.3 Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Introduction 11.13.4 Doctor's Best (Kingdomway) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) 11.13.5 Doctor's Best (Kingdomway) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Melatonin Table 3. Key Players of Ramelteon Table 4. Key Players of Others Table 5. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (2018-2023) & (US$ Million) Table 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2018-2023) Table 9. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 10. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2024-2029) Table 11. Circadian Rhythm Sleep Disorders Drug Market Trends Table 12. Circadian Rhythm Sleep Disorders Drug Market Drivers Table 13. Circadian Rhythm Sleep Disorders Drug Market Challenges Table 14. Circadian Rhythm Sleep Disorders Drug Market Restraints Table 15. Global Circadian Rhythm Sleep Disorders Drug Revenue by Players (2018-2023) & (US$ Million) Table 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players (2018-2023) Table 17. Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders Drug as of 2022) Table 18. Ranking of Global Top Circadian Rhythm Sleep Disorders Drug Companies by Revenue (US$ Million) in 2022 Table 19. Global 5 Largest Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue (CR5 and HHI) & (2018-2023) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Circadian Rhythm Sleep Disorders Drug Product Solution and Service Table 22. Date of Enter into Circadian Rhythm Sleep Disorders Drug Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Circadian Rhythm Sleep Disorders Drug Market Size by Type (2018-2023) & (US$ Million) Table 25. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2018-2023) Table 26. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 27. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2024-2029) Table 28. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2018-2023) & (US$ Million) Table 29. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2018-2023) Table 30. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 31. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2024-2029) Table 32. North America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 33. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) & (US$ Million) Table 34. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) & (US$ Million) Table 35. Europe Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) & (US$ Million) Table 37. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) & (US$ Million) Table 38. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 39. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2018-2023) & (US$ Million) Table 40. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2024-2029) & (US$ Million) Table 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 42. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) & (US$ Million) Table 43. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) & (US$ Million) Table 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2018-2023) & (US$ Million) Table 46. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2024-2029) & (US$ Million) Table 47. Teva Pharmaceuticals Company Detail Table 48. Teva Pharmaceuticals Business Overview Table 49. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product Table 50. Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 51. Teva Pharmaceuticals Recent Development Table 52. Takeda Pharmaceutical Company Detail Table 53. Takeda Pharmaceutical Business Overview Table 54. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product Table 55. Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 56. Takeda Pharmaceutical Recent Development Table 57. NBTY Company Detail Table 58. NBTY Business Overview Table 59. NBTY Circadian Rhythm Sleep Disorders Drug Product Table 60. NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 61. NBTY Recent Development Table 62. Vicks (Procter & Gamble) Company Detail Table 63. Vicks (Procter & Gamble) Business Overview Table 64. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product Table 65. Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 66. Vicks (Procter & Gamble) Recent Development Table 67. Natrol Company Detail Table 68. Natrol Business Overview Table 69. Natrol Circadian Rhythm Sleep Disorders Drug Product Table 70. Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 71. Natrol Recent Development Table 72. Nature Made (Pharmavite) Company Detail Table 73. Nature Made (Pharmavite) Business Overview Table 74. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product Table 75. Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 76. Nature Made (Pharmavite) Recent Development Table 77. Jameison Company Detail Table 78. Jameison Business Overview Table 79. Jameison Circadian Rhythm Sleep Disorders Drug Product Table 80. Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 81. Jameison Recent Development Table 82. GNC Company Detail Table 83. GNC Business Overview Table 84. GNC Circadian Rhythm Sleep Disorders Drug Product Table 85. GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 86. GNC Recent Development Table 87. By-Health Company Detail Table 88. By-Health Business Overview Table 89. By-Health Circadian Rhythm Sleep Disorders Drug Product Table 90. By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 91. By-Health Recent Development Table 92. Now Foods Company Detail Table 93. Now Foods Business Overview Table 94. Now Foods Circadian Rhythm Sleep Disorders Drug Product Table 95. Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 96. Now Foods Recent Development Table 97. Vitafusion (Church & Dwight) Company Detail Table 98. Vitafusion (Church & Dwight) Business Overview Table 99. Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Product Table 100. Vitafusion (Church & Dwight) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 101. Vitafusion (Church & Dwight) Recent Development Table 102. OLLY (Unilever) Company Detail Table 103. OLLY (Unilever) Business Overview Table 104. OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Product Table 105. OLLY (Unilever) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 106. OLLY (Unilever) Recent Development Table 107. Doctor's Best (Kingdomway) Company Detail Table 108. Doctor's Best (Kingdomway) Business Overview Table 109. Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Product Table 110. Doctor's Best (Kingdomway) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) & (US$ Million) Table 111. Doctor's Best (Kingdomway) Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Circadian Rhythm Sleep Disorders Drug Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Circadian Rhythm Sleep Disorders Drug Market Share by Type: 2022 VS 2029 Figure 3. Melatonin Features Figure 4. Ramelteon Features Figure 5. Others Features Figure 6. Global Circadian Rhythm Sleep Disorders Drug Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Circadian Rhythm Sleep Disorders Drug Market Share by Application: 2022 VS 2029 Figure 8. Delayed Sleep Phase Syndrome (DSPS) Case Studies Figure 9. Advanced Sleep Phase Syndrome (ASPS) Case Studies Figure 10. Irregular Sleep-Wake Disorder (ISWD) Case Studies Figure 11. Others Case Studies Figure 12. Circadian Rhythm Sleep Disorders Drug Report Years Considered Figure 13. Global Circadian Rhythm Sleep Disorders Drug Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Circadian Rhythm Sleep Disorders Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region: 2022 VS 2029 Figure 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players in 2022 Figure 17. Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders Drug as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue in 2022 Figure 19. North America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2018-2029) Figure 21. United States Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Circadian Rhythm Sleep Disorders Drug Market Share by Country (2018-2029) Figure 25. Germany Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Share by Region (2018-2029) Figure 33. China Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2018-2029) Figure 41. Mexico Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Share by Country (2018-2029) Figure 45. Turkey Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 49. NBTY Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 50. Vicks (Procter & Gamble) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 51. Natrol Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 52. Nature Made (Pharmavite) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 53. Jameison Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 54. GNC Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 55. By-Health Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 56. Now Foods Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 57. Vitafusion (Church & Dwight) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 58. OLLY (Unilever) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 59. Doctor's Best (Kingdomway) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2018-2023) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Teva Pharmaceuticals Takeda Pharmaceutical NBTY Vicks (Procter & Gamble) Natrol Nature Made (Pharmavite) Jameison GNC By-Health Now Foods Vitafusion (Church & Dwight) OLLY (Unilever) Doctor's Best (Kingdomway)